On April 18, 2024, Think Research Corporation, a TSXV-listed issuer focused on transforming healthcare through digital health software solutions, announced the closing of its sale to Beedie Investments Ltd., pursuant to which Beedie acquired all of the issued and outstanding common shares of Think Research by way of a court-approved plan of arrangement under the Business Corporations Act (Ontario). Under the terms of the arrangement, the shareholders of Think Research (other than Beedie and certain rolling shareholders) received cash consideration of $0.32 per common share. The transaction is valued at approximately $85 million.
Cassels acted for the Special Committee of Think Research.